intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi‐centre, acceptability and feasibility trial with nested qualitative methods
Addiction · 2025
DOI: 10.1111/add.16718 ↗At a glance
Multizentrische Studie in Addiction, 2025. Written by Gemma M J Taylor and 9 co-authors. Institution: Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, UK. Major MEDLINE topics: Smoking Cessation, Cognitive Behavioral Therapy, Anxiety Disorders, Depression. 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: The Centre for Primary Care at the University of Bristol, Higher Education Funding Council for England, NIHR Oxford Biomedical Research Centre.
Topics: Depression
Abstract (original language)
Background and aim There is evidence that smoking cessation may improve depression and anxiety symptoms. We assessed the feasibility of implementing and trialling a smoking cessation intervention in services providing cognitive behavioural therapy (CBT) for common mental illness. Design, setting and participants This study was a pragmatic, two‐armed, randomised, multi‐centre, acceptability and feasibility trial of a co‐designed smoking cessation intervention (ISRCTN99531779) involving United Kingdom National Health Service (NHS)‐funded services treating depression or anxiety among four NHS Trusts. Participants comprised adult daily smokers starting CBT for depression or anxiety [mean age 35.6 years, standard deviation (SD) = 12.7, 89.6% white] who smoked 14.3 (SD = 8.2) cigarettes/day with mean Generalised Anxiety Disorder Questionnaire‐7 (GAD‐7) and Patient Health Questionnaire‐9 (PHQ‐9) scores of 13.1 (SD = 4.9) and 14.5 (SD = 6.0). Sixty‐eight participants were allocated to the treatment group and 67 to control. Intervention and control Both groups received CBT for depression or anxiety. The treatment group also received up to 12 sessions of integrated smoking cessation support. The control group was signposted to smoking cessation services post‐treatment.
Measurements
Follow‐up was at 3 and 6 months. The primary outcome was ‘study completion’ by 3 months. Other outcomes included acceptability, satisfaction, feasibility, data completeness and mental health.
Findings
At 3 months, treatment did not affect study completion [odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.31 to 2.09], did not harm mental health (PHQ‐9 difference: coefficient 0.01, 95% CI = −2.19 to 2.22); GAD‐7: coefficient 0.65, 95% CI = −1.59 to 2.90), but increased abstinence rates (OR = 8.69, 95% CI = 1.11 to 396.26). Recruitment was acceptable and key stakeholders were satisfied with the intervention.
Conclusions
Among UK adult smokers receiving CBT treatment for depression or anxiety, a smoking cessation intervention within the CBT treatment was well received, did not interfere with the primary treatment goals and increased smoking cessation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath, UK.
- NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
- Bath Centre for Mindfulness and Compassion, Department of Psychology, University of Bath, Bath, UK.
- Bristol Trials Centre, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, UK.
- Centre for Academic Primary Care, Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK.
ORCID profiles: Gemma M J Taylor, Katherine Sawyer, Tom P Freeman, Shadi Daryan, Marcus R Munafò, Paul Aveyard
Funding
- The Centre for Primary Care at the University of Bristol
- Higher Education Funding Council for England
- NIHR Oxford Biomedical Research Centre
- NIHR Oxford Health Biomedical Research Centre
- Oxford and Thames Valley Applied Research Collaboration
- Cancer Research UK
- Medical Research Council
Cite
APA
Taylor, G. M. J., Sawyer, K., Jacobsen, P., Freeman, T. P., Blackwell, A., Daryan, S., Metcalfe, C., Kessler, D., Munafò, M. R., & Aveyard, P. (2025). intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi‐centre, acceptability and feasibility trial with nested qualitative methods. Addiction. https://doi.org/10.1111/add.16718
Vancouver
Taylor GMJ, Sawyer K, Jacobsen P, Freeman TP, Blackwell A, Daryan S, et al. intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi‐centre, acceptability and feasibility trial with nested qualitative methods. Addiction. 2025. doi:10.1111/add.16718
BibTeX
@article{Taylor2025,
author = {Taylor, Gemma M J and Sawyer, Katherine and Jacobsen, Pamela and Freeman, Tom P and Blackwell, Anna and Daryan, Shadi and Metcalfe, Chris and Kessler, David and Munafò, Marcus R and Aveyard, Paul},
title = {intEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): A randomised and controlled, multi‐centre, acceptability and feasibility trial with nested qualitative methods},
journal = {Addiction},
year = {2025},
doi = {10.1111/add.16718}
}
EUVIMED